Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient‐Derived Xenograft Models

BACKGROUND AND AIMS: Hepatoblastoma (HBL) is a devastating pediatric liver cancer with multiple treatment options, but it ultimately requires surgery for a cure. The most malicious form of HBL is a chemo‐resistant aggressive tumor that is characterized by rapid growth, metastases, and poor response...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, Michael Edward, Rivas, Maria Prates, Nicolle, Delphine, Gorse, Aurore, Gulati, Ruhi, Kumbaji, Meenasri, Weirauch, Matthew T., Bondoc, Alexander, Cairo, Stefano, Geller, James, Tiao, Gregory, Timchenko, Nikolai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463483/
https://www.ncbi.nlm.nih.gov/pubmed/34037269
http://dx.doi.org/10.1002/hep.31919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463483/
https://www.ncbi.nlm.nih.gov/pubmed/34037269
http://dx.doi.org/10.1002/hep.31919

Ejemplares similares